[ad_1]
German agrochemical giant Bayer appealed the decision of a US court to award US $ 78.5 million to a park worker who claimed that the use of the glyphosate weed killer society had given him cancer.
Last August, a California court sentenced Monsanto (since bought by Bayer) to pay US $ 289 million in compensation to Dewayne "Lee" Johnson, a former 46-year-old gardian who had been diagnosed with -Hodgkin's in 2014. after years of spraying Roundup, the company's best-selling herbicide.
In October, the court reduced the amount to be paid to Mr. Johnson to 78.5 million USD, following an appeal by Bayer.
See also: Opinion – life without glyphosate is difficult to envision
On Wednesday, April 24, Bayer asked a California court of appeal to quash the sentence passed on to Johnson.
In a statement, the company said there was "no evidence" that its glyphosate herbicides caused the cancer. "Bayer supports these products and will continue to defend them vigorously," said the company.
Bayer, who paid $ 63 billion for Monsanto last year, said he would be pushing for a new lawsuit if the decision was not reversed.
He added that the judge had prevented jurors from hearing evidence at the trial of the US Environmental Protection Agency and foreign regulatory authorities having concluded that glyphosate was safe and non-carcinogenic when used according to the label.
13,400 claims about glyphosate
Last month, a US court sentenced Bayer to pay $ 80 million to Edwin Hardeman, a retired 71-year-old California farmer, who claimed that his exposure to the company's herbicide had caused his lymphoma case. non-Hodgkin's.
About 13,400 complainants are prosecuted by Bayer for using glyphosate.
The company said: "Bayer continues to believe that she has meritorious defenses and intends to vigorously defend herself in all these lawsuits."
[ad_2]
Source link